Position in PGEN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$763,965
-$60,640 QoQ
Shares Held
197,407
+0.1% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. PGEN ranks #136 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in PGEN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $763,965 | 197,407 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $824,605 | 197,274 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $709,880 | 215,769 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $281,270 | 198,078 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $284,645 | 191,037 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $220,790 | 197,134 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $174,606 | 183,796 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $320,251 | 202,691 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $294,548 | 203,137 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $278,720 | 208,000 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $296,856 | 209,054 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $230,826 | 200,719 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $185,905 | 175,383 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $233,620 | 153,698 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $311,726 | 147,041 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $178,952 | 133,547 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $207,929 | 98,545 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $371,096 | 100,026 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $509,454 | 102,095 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $641,294 | 98,358 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $618,453 | 89,761 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $983,647 | 96,436 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $312,203 | 89,201 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $508,336 | 101,871 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $380,531 | 111,921 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||